title: Macular degeneration needs longer lasting treatments.
authors.affiliation: Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK jamestalks093@googlemail.com.
authors.forename: S James
authors.initials: SJ
authors.lastname: Talks
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D017277:Drug Approval; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy*; D012164:Retinal Diseases / Q000188:drug therapy*; D013222:State Medicine
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab